Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
In the last 90 days, Faeth Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
Superinvestors holding FTH, Q2 2026
No superinvestor reported holding FTH in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of FTH each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2024
0 superinvestors holding at quarter end
- Sold out
- Duquesne Family Office